James G. Granneman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
James G. Granneman has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
Emilio P. Mottillo
Center for Integrative Metabolic and Endocrine Research, Wayne State University School of Medicine, Detroit, MI 48202, USA
13 shared publicationsYun-Hee Lee
College of Pharmacy, Yonsei University, Incheon, South Korea
9 shared publicationsElizabeth A. Rondini
Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA
7 shared publications- Yun-Hee Lee
College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea
6 shared publications Hsiao-Ping H. Moore
The §Lawrence Technological University, Southfield, Michigan 48075
5 shared publicationsHuamei Zhang
5 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (11) , 101166
Lipid composition-driven sorting of ABHD5 between monolayer and bilayer surfaces
- 7 October 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (11) , 101166
Open AccessLipid composition-driven sorting of ABHD5 between monolayer and bilayer surfaces
- Open Access
Lipid composition-driven sorting of ABHD5 between monolayer and bilayer surfaces
Lipid droplets (LDs) are ubiquitous organelles that store neutral lipids and serve as central regulators of lipid homeostasis. Their structure includes a hydrophobic core of triacylglycerols and sterol esters surrounded by a phospholipid monolayer. This organization creates biophysical properties that guide selective protein recruitment. Among LD-associated proteins, α/β-hydrolase domain-containing protein 5 (ABHD5, also known as CGI-58) is a key regulator of lipolysis and broader lipid metabolism, yet the mechanisms guiding its distribution between endoplasmic reticulum (ER) bilayers and LD monolayers remain poorly understood. Because proper membrane association of ABHD5 is essential for activating PNPLA family lipases, identifying the determinants of its membrane selectivity is critical for understanding LD function in health and disease. In this study, we examined ABHD5 binding and sorting behavior using model membrane systems composed of giant unilamellar vesicles (GUVs) and droplet-embedded vesicles (DEVs) incorporating defined phospholipid and neutral lipid compositions. By integrating experimental assays with computational modeling, we quantified how ABHD5 partitions between bilayer membranes mimicking the ER and monolayer surfaces mimicking LDs. Systematic variation of membrane composition and physical properties allowed us to assess how packing defects and neutral lipid content shape ABHD5 localization. Our findings reveal the biophysical features that favor ABHD5 association with LD-like monolayers and provide new mechanistic insight into how cells target regulatory proteins to distinct membrane environments to control lipid metabolism.
Open AccessLipid composition-driven sorting of ABHD5 between monolayer and bilayer surfaces
Lipid droplets (LDs) are ubiquitous organelles that store neutral lipids and serve as central regulators of lipid homeostasis. Their structure includes a hydrophobic core of triacylglycerols and sterol esters surrounded by a phospholipid monolayer. This organization creates biophysical properties that guide selective protein recruitment. Among LD-associated proteins, α/β-hydrolase domain-containing protein 5 (ABHD5, also known as CGI-58) is a key regulator of lipolysis and broader lipid metabolism, yet the mechanisms guiding its distribution between endoplasmic reticulum (ER) bilayers and LD monolayers remain poorly understood. Because proper membrane association of ABHD5 is essential for activating PNPLA family lipases, identifying the determinants of its membrane selectivity is critical for understanding LD function in health and disease. In this study, we examined ABHD5 binding and sorting behavior using model membrane systems composed of giant unilamellar vesicles (GUVs) and droplet-embedded vesicles (DEVs) incorporating defined phospholipid and neutral lipid compositions. By integrating experimental assays with computational modeling, we quantified how ABHD5 partitions between bilayer membranes mimicking the ER and monolayer surfaces mimicking LDs. Systematic variation of membrane composition and physical properties allowed us to assess how packing defects and neutral lipid content shape ABHD5 localization. Our findings reveal the biophysical features that favor ABHD5 association with LD-like monolayers and provide new mechanistic insight into how cells target regulatory proteins to distinct membrane environments to control lipid metabolism.
- Open Access
- 6 August 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (9)
ABHD4-2: a cardiolipin-selective phospholipase of the outer mitochondrial membrane
- 6 August 2026
- Published by Elsevier in Journal of Lipid Research
- Vol. 67 (9)
Open AccessABHD4-2: a cardiolipin-selective phospholipase of the outer mitochondrial membrane
- Open Access
- 21 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
TMEM120A maintains adipose tissue lipid homeostasis through ER CoA channeling
Efficient fatty acid (FA) re-esterification is essential for lipid homeostasis in adipocytes, yet the mechanisms coordinating Coenzyme A (CoA) availability at the endoplasmic reticulum (ER)—a major site of lipid synthesis—remain unclear. Here, we identify TMEM120A as an ER-resident CoA-binding protein that regulates intracellular FA metabolism. TMEM120A interacts with the ER-localized acyl-CoA synthetase ACSL1 and ACSL3 to promote long-chain acyl-CoA synthesis and channeling into the ER, thereby facilitating FA re-esterification and lipid cycling during lipolysis. By relieving acyl-CoA-mediated feedback inhibition of lipolysis, TMEM120A enhances lipid turnover while protecting against ER stress and lipotoxicity. Adipocyte-specific deletion of Tmem120a in mice impairs lipolysis-induced energy expenditure and exacerbates inflammation and metabolic dysfunction under high-fat diet conditions. These findings establish TMEM120A as a critical regulator of ER CoA handling and lipid flux, revealing a previously unrecognized mechanism that links intracellular CoA dynamics to systemic energy balance and metabolic health.
- 21 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessTMEM120A maintains adipose tissue lipid homeostasis through ER CoA channeling
Efficient fatty acid (FA) re-esterification is essential for lipid homeostasis in adipocytes, yet the mechanisms coordinating Coenzyme A (CoA) availability at the endoplasmic reticulum (ER)—a major site of lipid synthesis—remain unclear. Here, we identify TMEM120A as an ER-resident CoA-binding protein that regulates intracellular FA metabolism. TMEM120A interacts with the ER-localized acyl-CoA synthetase ACSL1 and ACSL3 to promote long-chain acyl-CoA synthesis and channeling into the ER, thereby facilitating FA re-esterification and lipid cycling during lipolysis. By relieving acyl-CoA-mediated feedback inhibition of lipolysis, TMEM120A enhances lipid turnover while protecting against ER stress and lipotoxicity. Adipocyte-specific deletion of Tmem120a in mice impairs lipolysis-induced energy expenditure and exacerbates inflammation and metabolic dysfunction under high-fat diet conditions. These findings establish TMEM120A as a critical regulator of ER CoA handling and lipid flux, revealing a previously unrecognized mechanism that links intracellular CoA dynamics to systemic energy balance and metabolic health.
- Open Access
- 16 October 2025
- Published by Korean Society for the Study of Obesity in Journal of Obesity & Metabolic Syndrome
- Vol. 34 (4) , 362-377
Spatial Transcriptomics of Adipose Tissue: Technologies, Applications, and Challenges
A. K. Keesling, E. A. Rondini, James Granneman. J Obes Metab Syndr -0001;0:0-. https://doi.org/10.7570/jomes25078
- 16 October 2025
- Published by Korean Society for the Study of Obesity in Journal of Obesity & Metabolic Syndrome
- Vol. 34 (4) , 362-377
Open AccessSpatial Transcriptomics of Adipose Tissue: Technologies, Applications, and Challenges
A. K. Keesling, E. A. Rondini, James Granneman. J Obes Metab Syndr -0001;0:0-. https://doi.org/10.7570/jomes25078
- Open Access
- 10 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Dynamic sampling from ex vivo adipose tissue using droplet-based microfluidics supports separate mechanisms for glycerol and fatty acid secretion
Pathologies in adipose (fat) tissue function are linked with human diseases such as diabetes, obesity, metabolic syndrome, and cancer. Dynamic, rapid release of metabolites has been observed in adipocyte cells and tissue, yet higher temporal resolution is needed to adequately study this process. In this work, a microfluidic device with precise and regular valve-automated droplet sampling, termed a microfluidic analog-to-digital converter (µADC), was used to sample secretions from ~0.75 mm diameter adipose explants from mice, and on-chip salt water electrodes were used to merge sampled droplets with reagent droplets from two different fluorometric coupled enzyme assays. By integrating sampling and assays on-chip, either glycerol or non-esterified fatty acids (NEFA), or both, were quantified optically within merged 12-nanoliter droplets using a fluorescence microscope with as high as 20-second temporal resolution. Limits of detection were 6 µM for glycerol (70 fmol) and 0.9 µM for NEFA (10 fmol). Multiple ex vivo adipose tissue explants were analyzed with this system, all showing clear increases in lipolytic function after switching from feeding to fasting conditions. Enabled by high temporal resolution, lipolytic oscillations of both glycerol and NEFA were observed for the first time in the range of 0.2 to 1.6 min-1. Continuous wavelet transform (CWT) spectrograms and burst analyses (0.1 to 4.0 pmol bursts) revealed complex dynamics, with multiplexed assays (duplex for glycerol and NEFA) from the same explants showing mostly discordant bursts. These data support separate mechanisms of NEFA and glycerol release, although the connection to intracellular metabolic oscillations remains unknown. Overall, this device allowed automated and highly precise temporal sampling of tissue explants at high resolution and programmable downstream merging with multiple assay reagents, revealing unique biological information. Such device features should be applicable to various other tissue or spheroid types and to other assay formats.
- 10 September 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessDynamic sampling from ex vivo adipose tissue using droplet-based microfluidics supports separate mechanisms for glycerol and fatty acid secretion
Pathologies in adipose (fat) tissue function are linked with human diseases such as diabetes, obesity, metabolic syndrome, and cancer. Dynamic, rapid release of metabolites has been observed in adipocyte cells and tissue, yet higher temporal resolution is needed to adequately study this process. In this work, a microfluidic device with precise and regular valve-automated droplet sampling, termed a microfluidic analog-to-digital converter (µADC), was used to sample secretions from ~0.75 mm diameter adipose explants from mice, and on-chip salt water electrodes were used to merge sampled droplets with reagent droplets from two different fluorometric coupled enzyme assays. By integrating sampling and assays on-chip, either glycerol or non-esterified fatty acids (NEFA), or both, were quantified optically within merged 12-nanoliter droplets using a fluorescence microscope with as high as 20-second temporal resolution. Limits of detection were 6 µM for glycerol (70 fmol) and 0.9 µM for NEFA (10 fmol). Multiple ex vivo adipose tissue explants were analyzed with this system, all showing clear increases in lipolytic function after switching from feeding to fasting conditions. Enabled by high temporal resolution, lipolytic oscillations of both glycerol and NEFA were observed for the first time in the range of 0.2 to 1.6 min-1. Continuous wavelet transform (CWT) spectrograms and burst analyses (0.1 to 4.0 pmol bursts) revealed complex dynamics, with multiplexed assays (duplex for glycerol and NEFA) from the same explants showing mostly discordant bursts. These data support separate mechanisms of NEFA and glycerol release, although the connection to intracellular metabolic oscillations remains unknown. Overall, this device allowed automated and highly precise temporal sampling of tissue explants at high resolution and programmable downstream merging with multiple assay reagents, revealing unique biological information. Such device features should be applicable to various other tissue or spheroid types and to other assay formats.
- Open Access
- 30 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-21
TM4SF19-mediated control of lysosomal activity in macrophages contributes to obesity-induced inflammation and metabolic dysfunction
Adipose tissue (AT) adapts to overnutrition in a complex process, wherein specialized immune cells remove and replace dysfunctional and stressed adipocytes with new fat cells. Among immune cells recruited to AT, lipid-associated macrophages (LAMs) have emerged as key players in obesity and in diseases involving lipid stress and inflammation. Here, we show that LAMs selectively express transmembrane 4 L six family member 19 (TM4SF19), a lysosomal protein that represses acidification through its interaction with Vacuolar-ATPase. Inactivation of TM4SF19 elevates lysosomal acidification and accelerates the clearance of dying/dead adipocytes in vitro and in vivo. TM4SF19 deletion reduces the LAM accumulation and increases the proportion of restorative macrophages in AT of male mice fed a high-fat diet. Importantly, male mice lacking TM4SF19 adapt to high-fat feeding through adipocyte hyperplasia, rather than hypertrophy. This adaptation significantly improves local and systemic insulin sensitivity, and energy expenditure, offering a potential avenue to combat obesity-related metabolic dysfunction.
- 30 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-21
Open AccessTM4SF19-mediated control of lysosomal activity in macrophages contributes to obesity-induced inflammation and metabolic dysfunction
Adipose tissue (AT) adapts to overnutrition in a complex process, wherein specialized immune cells remove and replace dysfunctional and stressed adipocytes with new fat cells. Among immune cells recruited to AT, lipid-associated macrophages (LAMs) have emerged as key players in obesity and in diseases involving lipid stress and inflammation. Here, we show that LAMs selectively express transmembrane 4 L six family member 19 (TM4SF19), a lysosomal protein that represses acidification through its interaction with Vacuolar-ATPase. Inactivation of TM4SF19 elevates lysosomal acidification and accelerates the clearance of dying/dead adipocytes in vitro and in vivo. TM4SF19 deletion reduces the LAM accumulation and increases the proportion of restorative macrophages in AT of male mice fed a high-fat diet. Importantly, male mice lacking TM4SF19 adapt to high-fat feeding through adipocyte hyperplasia, rather than hypertrophy. This adaptation significantly improves local and systemic insulin sensitivity, and energy expenditure, offering a potential avenue to combat obesity-related metabolic dysfunction.
- Open Access
- 24 April 2023
- Published by Springer Nature in Research Square
TM4SF19-mediated brake of macrophage efferocytosis contributes to obesity-induced inflammation of adipose tissue
Adipose tissue macrophages are critical players in obesity-induced inflammation and metabolic dysfunction. Here, we identify transmembrane 4 L six family member 19 (TM4SF19) as a gene upregulated in adipose tissue macrophages in obese states. We demonstrate that TM4SF19 is a lysosomal membrane protein that inhibits vacuolar H+-ATPase activity by interacting with its subunit ATP6V0B. In vitro gain- and loss-of-function assays in macrophages indicate that TM4SF19 reduces lysosomal acidification and impairs the clearance of dead fat cells. Single-nucleus RNA sequencing analysis indicates that TM4SF19 is specifically expressed in a subpopulation of Trem2 + lipid-associated macrophages, and global knockout reduces diet-induced obesity and recruitment of pro-inflammatory macrophages to adipose tissue. Moreover, global or macrophage-specific TM4SF19 knockout decreases the number of lipid-stressed adipocytes induced by high-fat feeding and restores tissue insulin sensitivity. Overall, these results suggest that TM4SF19-mediated control of lysosomal activity is a potential therapeutic target to resolve obesity-induced adipose tissue inflammation.
- 24 April 2023
- Published by Springer Nature in Research Square
Open AccessTM4SF19-mediated brake of macrophage efferocytosis contributes to obesity-induced inflammation of adipose tissue
Adipose tissue macrophages are critical players in obesity-induced inflammation and metabolic dysfunction. Here, we identify transmembrane 4 L six family member 19 (TM4SF19) as a gene upregulated in adipose tissue macrophages in obese states. We demonstrate that TM4SF19 is a lysosomal membrane protein that inhibits vacuolar H+-ATPase activity by interacting with its subunit ATP6V0B. In vitro gain- and loss-of-function assays in macrophages indicate that TM4SF19 reduces lysosomal acidification and impairs the clearance of dead fat cells. Single-nucleus RNA sequencing analysis indicates that TM4SF19 is specifically expressed in a subpopulation of Trem2 + lipid-associated macrophages, and global knockout reduces diet-induced obesity and recruitment of pro-inflammatory macrophages to adipose tissue. Moreover, global or macrophage-specific TM4SF19 knockout decreases the number of lipid-stressed adipocytes induced by high-fat feeding and restores tissue insulin sensitivity. Overall, these results suggest that TM4SF19-mediated control of lysosomal activity is a potential therapeutic target to resolve obesity-induced adipose tissue inflammation.
- Open Access
- 21 April 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
DNALI1 interacts with the MEIG1/PACRG complex within the manchette and is required for proper sperm flagellum assembly in mice
The manchette is a transient and unique structure present in elongating spermatids and required for proper differentiation of the germ cells during spermatogenesis. Previous work indicated that the MEIG1/PACRG complex locates in the manchette and is involved in the transport of cargos, such as SPAG16L, to build the sperm flagellum. Here, using co-immunoprecipitation and pull-down approaches in various cell systems, we established that DNALI1, an axonemal component originally cloned from Chlamydomonas reinhardtii, recruits and stabilizes PACRG and we confirm in vivo, the co-localization of DNALI1 and PACRG in the manchette by immunofluorescence of elongating murine spermatids. We next generated mice with a specific deficiency of DNALI1 in male germ cells, and observed a dramatic reduction of the sperm cells, which results in male infertility. In addition, we observed that the majority of the sperm cells exhibited abnormal morphology including misshapen heads, bent tails, enlarged midpiece, discontinuous accessory structure, emphasizing the importance of DNALI1 in sperm differentiation. Examination of testis histology confirmed impaired spermiogenesis in the mutant mice. Importantly, while testicular levels of MEIG1, PACRG, and SPAG16L proteins were unchanged in the Dnali1 mutant mice, their localization within the manchette was greatly affected, indicating that DNALI1 is required for the formation of the MEIG1/PACRG complex within the manchette. Interestingly, in contrast to MEIG1 and PACRG-deficient mice, the DNALI1-deficient mice also showed impaired sperm spermiation/individualization, suggesting additional functions beyond its involvement in the manchette structure. Overall, our work identifies DNALI1 as a protein required for sperm development.
- 21 April 2023
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 12
Open AccessDNALI1 interacts with the MEIG1/PACRG complex within the manchette and is required for proper sperm flagellum assembly in mice
The manchette is a transient and unique structure present in elongating spermatids and required for proper differentiation of the germ cells during spermatogenesis. Previous work indicated that the MEIG1/PACRG complex locates in the manchette and is involved in the transport of cargos, such as SPAG16L, to build the sperm flagellum. Here, using co-immunoprecipitation and pull-down approaches in various cell systems, we established that DNALI1, an axonemal component originally cloned from Chlamydomonas reinhardtii, recruits and stabilizes PACRG and we confirm in vivo, the co-localization of DNALI1 and PACRG in the manchette by immunofluorescence of elongating murine spermatids. We next generated mice with a specific deficiency of DNALI1 in male germ cells, and observed a dramatic reduction of the sperm cells, which results in male infertility. In addition, we observed that the majority of the sperm cells exhibited abnormal morphology including misshapen heads, bent tails, enlarged midpiece, discontinuous accessory structure, emphasizing the importance of DNALI1 in sperm differentiation. Examination of testis histology confirmed impaired spermiogenesis in the mutant mice. Importantly, while testicular levels of MEIG1, PACRG, and SPAG16L proteins were unchanged in the Dnali1 mutant mice, their localization within the manchette was greatly affected, indicating that DNALI1 is required for the formation of the MEIG1/PACRG complex within the manchette. Interestingly, in contrast to MEIG1 and PACRG-deficient mice, the DNALI1-deficient mice also showed impaired sperm spermiation/individualization, suggesting additional functions beyond its involvement in the manchette structure. Overall, our work identifies DNALI1 as a protein required for sperm development.
- Open Access
Four-color fluorescence cross-correlation spectroscopy with one laser and one camera
The diffusion and reorganization of phospholipids and membrane-associated proteins are fundamental for cellular function. Fluorescence cross-correlation spectroscopy (FCCS) measures the diffusion and molecular interactions at nanomolar concentration in biological systems. We have developed a novel, economical method to simultaneously monitor diffusion and oligomerization with the use of super-continuum laser and spectral deconvolution from a single detector. Customizable excitation wavelengths were chosen from the wide-band source and spectral fitting of the emitted light revealed the interactions for up to four spectrally overlapping fluorophores simultaneously. This method was applied to perform four-color FCCS, as demonstrated with polystyrene nanoparticles, lipid vesicles, and membrane-bound molecules. Up to four individually customizable excitation channels were selected from the broad-spectrum fiber laser to excite the diffusers within a diffraction-limited spot. The fluorescence emission passed through a cleanup filter and a dispersive prism prior to being collected by a sCMOS or EMCCD camera with up to 10 kHz frame rates. The emission intensity versus time of each fluorophore was extracted through a linear least-square fitting of each camera frame and temporally correlated via custom software. Auto- and cross-correlation functions enabled the measurement of the diffusion rates and binding partners. We have measured the induced aggregation of nanobeads and lipid vesicles in solution upon increasing the buffer salinity. Because of the adaptability of investigating four fluorophores simultaneously with a cost-effective method, this technique will have wide application for examining complex homo- and heterooligomerization in model and living systems.
Open AccessFour-color fluorescence cross-correlation spectroscopy with one laser and one camera
The diffusion and reorganization of phospholipids and membrane-associated proteins are fundamental for cellular function. Fluorescence cross-correlation spectroscopy (FCCS) measures the diffusion and molecular interactions at nanomolar concentration in biological systems. We have developed a novel, economical method to simultaneously monitor diffusion and oligomerization with the use of super-continuum laser and spectral deconvolution from a single detector. Customizable excitation wavelengths were chosen from the wide-band source and spectral fitting of the emitted light revealed the interactions for up to four spectrally overlapping fluorophores simultaneously. This method was applied to perform four-color FCCS, as demonstrated with polystyrene nanoparticles, lipid vesicles, and membrane-bound molecules. Up to four individually customizable excitation channels were selected from the broad-spectrum fiber laser to excite the diffusers within a diffraction-limited spot. The fluorescence emission passed through a cleanup filter and a dispersive prism prior to being collected by a sCMOS or EMCCD camera with up to 10 kHz frame rates. The emission intensity versus time of each fluorophore was extracted through a linear least-square fitting of each camera frame and temporally correlated via custom software. Auto- and cross-correlation functions enabled the measurement of the diffusion rates and binding partners. We have measured the induced aggregation of nanobeads and lipid vesicles in solution upon increasing the buffer salinity. Because of the adaptability of investigating four fluorophores simultaneously with a cost-effective method, this technique will have wide application for examining complex homo- and heterooligomerization in model and living systems.